Top 5 Trends in Non Compliance in Pharmaceutical Manufacturing

Pharmaceutical companies operate in one of the most dynamic environments. Changes in regulations by leading bodies such as US Food and Drug Administration (USFDA) and the European Medicines Agency (EMA) have increased the significance of regulatory compliance management for drug manufacturers. We analysed a total of 155 warning letters issued by FDA's Office of Manufacturing Quality (OMQ) from 2015-2018. The infographic below illustrates the findings. 

merge_from_ofoct (3)


Posted on Jul 11, 2018 3:56:14 PM by Vivek Gera

Vivek Gera

Written by Vivek Gera

Vivek is the CEO of LeucineTech, a digital compliance platform that reduces the risk of drug FDA non-compliance (due to cross-contamination) by 80%.

Subscribe to Email Updates

Lists by Topic

Recent Posts

Posts by Topic